Clinical Trial Update: Carbon Monoxide Therapy for Severe Pulmonary Arterial Hypertension [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating carbon monoxide therapy for severe pulmonary arterial hypertension was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Carbon Monoxide (carbon monoxide)

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Hypertension, Pulmonary | Phase 1, Phase 2 | Status: WITHDRAWN